178 related articles for article (PubMed ID: 32893091)
1. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
[TBL] [Abstract][Full Text] [Related]
3. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
[TBL] [Abstract][Full Text] [Related]
5. White matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control.
Koini M; Rombouts SARB; Veer IM; Van Buchem MA; Huijbregts SCJ
Brain Imaging Behav; 2017 Dec; 11(6):1731-1740. PubMed ID: 27796732
[TBL] [Abstract][Full Text] [Related]
6. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
[TBL] [Abstract][Full Text] [Related]
7. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
8. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
10. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
11. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
[TBL] [Abstract][Full Text] [Related]
12. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
[TBL] [Abstract][Full Text] [Related]
14. Alterations in white matter microstructure in neurofibromatosis-1.
Karlsgodt KH; Rosser T; Lutkenhoff ES; Cannon TD; Silva A; Bearden CE
PLoS One; 2012; 7(10):e47854. PubMed ID: 23094098
[TBL] [Abstract][Full Text] [Related]
15. White matter is increased in the brains of adults with neurofibromatosis 1.
Wang S; Friedman JM; Suppa P; Buchert R; Mautner VF
Orphanet J Rare Dis; 2022 Mar; 17(1):115. PubMed ID: 35248131
[TBL] [Abstract][Full Text] [Related]
16. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.
Ferraz-Filho JR; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Pediatr Radiol; 2012 Apr; 42(4):449-54. PubMed ID: 22033857
[TBL] [Abstract][Full Text] [Related]
17. Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.
Loitfelder M; Huijbregts SC; Veer IM; Swaab HS; Van Buchem MA; Schmidt R; Rombouts SA
Brain Connect; 2015 Jun; 5(5):312-20. PubMed ID: 25705926
[TBL] [Abstract][Full Text] [Related]
18. Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.
Duarte JV; Ribeiro MJ; Violante IR; Cunha G; Silva E; Castelo-Branco M
Hum Brain Mapp; 2014 Jan; 35(1):89-106. PubMed ID: 22965669
[TBL] [Abstract][Full Text] [Related]
19. Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review.
Baudou E; Nemmi F; Biotteau M; Maziero S; Peran P; Chaix Y
Front Neurol; 2019; 10():1373. PubMed ID: 31993017
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the basal ganglia in neurofibromatosis type 1.
Nicita F; Di Biasi C; Sollaku S; Cecchini S; Salpietro V; Pittalis A; Papetti L; Ursitti F; Ulgiati F; Zicari AM; Gualdi GF; Properzi E; Duse M; Ruggieri M; Spalice A
Childs Nerv Syst; 2014 Feb; 30(2):319-25. PubMed ID: 23892392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
